chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Syncope
Clinical narrative: Vasovagal syncope, anxiety
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Dizziness, Vomiting
Clinical narrative: the patient became dizzy then vomited then complained about some stomachache .
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Numbness and tingling in arms and legs, from finger tips to elbows.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy test positive, Biopsy, Blood test, Condition aggravated, Hypersensitivity
Clinical narrative: About 12 hours after receiving my first dose, I broke out in a rash from head to toe. I was given a steroid shot and allergy pills to calm the rash. I waited the full 6 six weeks to get my second dose. About 12 hours after receiving my second dose, I had the same reaction. The reaction after the second dose was not as strong at first, but it gradually became as strong a reaction as the first.  I saw a total of five different doctors. I saw two different allergists. The second allergist I saw, performed allergy tests on me that pertain to the vaccine. It turns out that I am allergic to polyethylene glycol. I have never had this allergy, or wasn't aware of having it, prior to receiving my vaccines. The allergist kept thinking that I had a rash around the injection site, but I never had one there. It was just everywhere else.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Rash, Urine analysis
Clinical narrative: About 12 hours after receiving my first dose, I broke out in a rash from head to toe. I was given a steroid shot and allergy pills to calm the rash. I waited the full 6 six weeks to get my second dose. About 12 hours after receiving my second dose, I had the same reaction. The reaction after the second dose was not as strong at first, but it gradually became as strong a reaction as the first.  I saw a total of five different doctors. I saw two different allergists. The second allergist I saw, performed allergy tests on me that pertain to the vaccine. It turns out that I am allergic to polyethylene glycol. I have never had this allergy, or wasn't aware of having it, prior to receiving my vaccines. The allergist kept thinking that I had a rash around the injection site, but I never had one there. It was just everywhere else.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: After getting 2nd covid vaccine by Pfizer, she had sore arm and sore body. She received the vaccine on 12/6/21 2pm and came back to pharmacy on 1/15/22 11:30am with saying she still have her arm sore and body sore pain, and she kept claiming that is allergic reaction. I told her allergic reaction usually happens with symptoms of difficulty in breathing and hives or so but she kept insisting she suffers from allergic reaction. She said she always had problems with all the previous flushots and also with  with this 2nd covid vaccine, so she wanted me to report. I told her not to touch the sore area and keep circulating blood and body but she said that's not helping and causing more pain.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Exposure to SARS-CoV-2, Fine motor skill dysfunction, Impaired work ability, Inflammation, Joint swelling
Clinical narrative: Approximately 5days after vaccination nodules on my fingers became inflamed & got bigger also developed nodules right below my knees also developed nodules on my toes  With every subsequent vaccination nodules became more inflamed & increase in number of nodules 3shot my hands & wrists developed swelling Was prescribed prednisone which helped a little. Nodules still increased in size sometimes my dexterity is bad Had to retire from work since I can?t start ivs as well & increased pain when working Now I had a very close exposure to my daughter-in-law who just tested positive for COVID & my joints & nodules are swollen. This started 3 days after exposure
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nodule, Pain, Peripheral swelling
Clinical narrative: Approximately 5days after vaccination nodules on my fingers became inflamed & got bigger also developed nodules right below my knees also developed nodules on my toes  With every subsequent vaccination nodules became more inflamed & increase in number of nodules 3shot my hands & wrists developed swelling Was prescribed prednisone which helped a little. Nodules still increased in size sometimes my dexterity is bad Had to retire from work since I can?t start ivs as well & increased pain when working Now I had a very close exposure to my daughter-in-law who just tested positive for COVID & my joints & nodules are swollen. This started 3 days after exposure
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: During a review of  records, it was found that there might have been a possible temperature excursion with how the vaccine was stored with our mobile vendor.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Vitamin D decreased
Clinical narrative: Age: 45 at time of 1st dose (9/22/21) and 46 at time of 2nd dose (10/13/21)- both around 8:30am   Female Pfizer BioNTech (lot: EW0182) received at the Health Center I started losing large amounts of hair every time I washed my hair, and a lot more than usual was falling out throughout the day. This began immediately (9/23/21). After a friend suggested I take Vitamin D, I began taking it on 12/6/21. The major hair loss stopped immediately. In this 2 1/2 months, I lost about half my hair.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Patient developed full body rash within 24 hours of receiving vaccine.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chest discomfort, Dyspnoea, Fatigue, Headache
Clinical narrative: Left shoulder/injection site pain. Pressure around the heart, slight difficulty breathing with exertion, fatigue, headache, joint pain and mild rash/hives.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Rash, Urticaria
Clinical narrative: Left shoulder/injection site pain. Pressure around the heart, slight difficulty breathing with exertion, fatigue, headache, joint pain and mild rash/hives.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: During a review of the local Health Dept. internal records, it was found that there might have been a possible temperature excursion with how the vaccine was stored with our mobile vendor.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Dyspnoea, Feeling hot, Flushing, Tremor
Clinical narrative: 36 yo patient received her Pfizer booster at  Covid clinic on 01/15/2022. Vaccine given at 1407 in left deltoid. Lot number was FJ5682, expiration 04/01/2022. Patient had no reaction after first 2 pfizer vaccines.Patient wanted to stay for 15 minute observation.   Within the first 2-4 minutes after vaccine she developed warm feeling all over and was flushed, she felt she had a hard time taking a deep breath. She was given water and she said she felt better. At 2:25  she said she was feeling shaky and appeared very anxious.She was laid down on the cart and her BP was 144/84, pulse ox 100, HR 140. She was encouraged to take slow deep breaths and sips of water. She denied itchy feeling or difficulty swallowing.She continued to have feelings of not getting enough breath and emergency was called at 2:45.The squad came at 2:50 and placed her on gurney to transport to ER. She called her mother prior to leaving Covid Clinic.  She has allergy to Penicillin. No present illness. She has a history of depression and Anxiety but has been off medication x 1 year. She took no medication earlier today.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Blood culture negative, COVID-19, Chest X-ray normal, Condition aggravated
Clinical narrative: Patient was hospitalized due to breakthrough COVID-19 infection. Patient received 2nd dose of vaccine on 08/21/2021. Patient was hospitalized from 12/21/21 to 12/23/21. Below is copied from discharge summary:   Hospital Course:  Patient is a 26 y/o F with Hx of sickle cell anemia and HTN who presents with back pain today, found meeting sepsis criteria with likely viral illness as source vs other and with elevated ret countconsistent with sickle cell crisis.   Sepsis with acute organ dysfunction likely 2/2 COVID -Meeting sepsis on admit based on fever, tachycardia and suspected source of infection -LA of 2 -> 0.7 -BCx2 NGTD -UA WNL -Chest Xray clear -Resp panel with COVID   Acute sickle cell crisis/ Sickle cell anemia/ Acute on chronic back pain on chronic opioids: -Hgb stable at 9gr    HTN: -Controlled -Resume home meds   GERD: -Resume ppi   Marijuana use: -Would benefit from cessation   Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP MD within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Gastrooesophageal reflux disease, Haemoglobin decreased, Pyrexia, Respiratory viral panel, Reticulocyte count increased
Clinical narrative: Patient was hospitalized due to breakthrough COVID-19 infection. Patient received 2nd dose of vaccine on 08/21/2021. Patient was hospitalized from 12/21/21 to 12/23/21. Below is copied from discharge summary:   Hospital Course:  Patient is a 26 y/o F with Hx of sickle cell anemia and HTN who presents with back pain today, found meeting sepsis criteria with likely viral illness as source vs other and with elevated ret countconsistent with sickle cell crisis.   Sepsis with acute organ dysfunction likely 2/2 COVID -Meeting sepsis on admit based on fever, tachycardia and suspected source of infection -LA of 2 -> 0.7 -BCx2 NGTD -UA WNL -Chest Xray clear -Resp panel with COVID   Acute sickle cell crisis/ Sickle cell anemia/ Acute on chronic back pain on chronic opioids: -Hgb stable at 9gr    HTN: -Controlled -Resume home meds   GERD: -Resume ppi   Marijuana use: -Would benefit from cessation   Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP MD within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Sepsis, Sickle cell anaemia, Sickle cell anaemia with crisis, Substance use
Clinical narrative: Patient was hospitalized due to breakthrough COVID-19 infection. Patient received 2nd dose of vaccine on 08/21/2021. Patient was hospitalized from 12/21/21 to 12/23/21. Below is copied from discharge summary:   Hospital Course:  Patient is a 26 y/o F with Hx of sickle cell anemia and HTN who presents with back pain today, found meeting sepsis criteria with likely viral illness as source vs other and with elevated ret countconsistent with sickle cell crisis.   Sepsis with acute organ dysfunction likely 2/2 COVID -Meeting sepsis on admit based on fever, tachycardia and suspected source of infection -LA of 2 -> 0.7 -BCx2 NGTD -UA WNL -Chest Xray clear -Resp panel with COVID   Acute sickle cell crisis/ Sickle cell anemia/ Acute on chronic back pain on chronic opioids: -Hgb stable at 9gr    HTN: -Controlled -Resume home meds   GERD: -Resume ppi   Marijuana use: -Would benefit from cessation   Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP MD within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tachycardia, Urine analysis normal, Vaccine breakthrough infection, Viral infection
Clinical narrative: Patient was hospitalized due to breakthrough COVID-19 infection. Patient received 2nd dose of vaccine on 08/21/2021. Patient was hospitalized from 12/21/21 to 12/23/21. Below is copied from discharge summary:   Hospital Course:  Patient is a 26 y/o F with Hx of sickle cell anemia and HTN who presents with back pain today, found meeting sepsis criteria with likely viral illness as source vs other and with elevated ret countconsistent with sickle cell crisis.   Sepsis with acute organ dysfunction likely 2/2 COVID -Meeting sepsis on admit based on fever, tachycardia and suspected source of infection -LA of 2 -> 0.7 -BCx2 NGTD -UA WNL -Chest Xray clear -Resp panel with COVID   Acute sickle cell crisis/ Sickle cell anemia/ Acute on chronic back pain on chronic opioids: -Hgb stable at 9gr    HTN: -Controlled -Resume home meds   GERD: -Resume ppi   Marijuana use: -Would benefit from cessation   Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP MD within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Patient stated to staff that his MD told him that he needed a 4th dose due to being immunocompromised. Patient was given a 4th dose without verifying info with lead.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: During a review of the local Health Dept. internal records, it was found that there might have been a possible temperature excursion with how the vaccine was stored with our mobile vendor.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Dermatitis, Erythema, Pruritus, Rash
Clinical narrative: Whole body skin rash. Red inflammation that looks like sunburn, no raises bumps, but very itchy when untreated. Occurs randomly on different body parts/areas and goes away with over the counter antihistamines Allegra and Claritin. Worst rash happens after taking a hot shower. Started 12/23/2021 and has continued through 01/15/2022.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Bell's palsy, Computerised tomogram head normal, Facial paralysis, Hypoacusis, Hypoaesthesia oral
Clinical narrative: Bells Palsy onset at 10:00 am on 5 Jan 2021 beginning with hearing issues.  Evening of 7 Jun 2021 at 05:00 PM sense of numbness in lower lip.  Morning of 8 Jun 2021 at 5:30 complete lack of muscle control of left side of face.  8 Jun 2021 03:00 pm diagnosis by physician of suspected Bells Palsy and prescription of steroids.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Mechanical urticaria, Pruritus, Urticaria
Clinical narrative: Global outbreak of hives, intense itch, and dermatographia. Day 1: Started on my scalp, dorsal neck, and ears; then Days 2 - 10 radiated to all parts of my body. Now (Day 17) they appear spontaneously anywhere on my body throughout the day. If scratched, will become an uncomfortable patch of wheals. If left alone, will go away in an hour or so. Dermatographia persistent 100%.   Treatment: Tapered prednisolone course (40 mg  per day slowly tapered down); Cetirizine 10 mg BID; Famotidine 10 mg BID; Vitamin C supplement. Topical Triamcinolone cream PRN.  25 mg Benadryl added in PM only as needed.   Current Day 17:  Vastly improved but not resolved. When medications wear off ~ q 12 hours, or if I miss a dose, prevalence and intensity of hives starts to ramp up.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: During a review of the Local Health Dept. internal records, it was found that there might have been a possible temperature excursion with how the vaccine was stored with our mobile vendor.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspepsia, Heart rate increased, Injection site pain, Pyrexia
Clinical narrative: Accelerated heart rate: Resting/sleeping rate increased from a normal of 60 to 85-90. Active rate increased to 100.   Increase lasted 36-40 hours. Had mild center chest pain, similar to indigestion that was not relieved by Gaviscon. Also had severe soreness at injection site, as well as a slight fever.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Consciousness fluctuating, Depression, Dyspnoea, Fatigue
Clinical narrative: The night after I was vaccinated, I awoke multiple times desperately gasping for air. I do not have apnea or anything like that; it was from the booster shot.  I was feeling progressively worse and worse and by about 6 AM on the 24th of December, I began vomiting more violently than is typical for me when sick. I was drifting in and out of consciousness throughout the morning, only to be awaken by the same gasping for air, except now the gasping was accompanied by a severe need to vomit.  By the evening the vomiting had subsided but I was still extremely nauseous, occasionally out of breath for no reason, and feeling very exhausted.   I did not get out of bed for two days except to vomit, refill my water,  and use the facilities. For two weeks days after the booster shot I was overcome with moderately severe depression.  My body was inflamed for three weeks, with my rings difficult to remove from my fingers. I had a migraine for a week straight after receiving the booster.  It is by far the most sick I have ever been after receiving any type of vaccination.   Oddly enough, the booster left my arm feeling sore for much less time than the first two shots did. But everything else aside from my arm was much, much worse with the booster.   If I had not already been on vacation, I would have missed at least four days of work due to how sick I was from the booster.  The only lingering symptoms I have as of Jan 15, 2020 are very mild global inflammation and depression (more than I normally have)   For this reason, I answered "unknown" for question #20  The side effects I experienced were alarming enough that  I would have gone to the ER under normal circumstances, but I did not go because the hospitals are overwhelmed with covid patients right now.   I did mention the symptoms to the physician's assistant last time I was seen though.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Inflammation, Migraine, Mobility decreased, Nausea
Clinical narrative: The night after I was vaccinated, I awoke multiple times desperately gasping for air. I do not have apnea or anything like that; it was from the booster shot.  I was feeling progressively worse and worse and by about 6 AM on the 24th of December, I began vomiting more violently than is typical for me when sick. I was drifting in and out of consciousness throughout the morning, only to be awaken by the same gasping for air, except now the gasping was accompanied by a severe need to vomit.  By the evening the vomiting had subsided but I was still extremely nauseous, occasionally out of breath for no reason, and feeling very exhausted.   I did not get out of bed for two days except to vomit, refill my water,  and use the facilities. For two weeks days after the booster shot I was overcome with moderately severe depression.  My body was inflamed for three weeks, with my rings difficult to remove from my fingers. I had a migraine for a week straight after receiving the booster.  It is by far the most sick I have ever been after receiving any type of vaccination.   Oddly enough, the booster left my arm feeling sore for much less time than the first two shots did. But everything else aside from my arm was much, much worse with the booster.   If I had not already been on vacation, I would have missed at least four days of work due to how sick I was from the booster.  The only lingering symptoms I have as of Jan 15, 2020 are very mild global inflammation and depression (more than I normally have)   For this reason, I answered "unknown" for question #20  The side effects I experienced were alarming enough that  I would have gone to the ER under normal circumstances, but I did not go because the hospitals are overwhelmed with covid patients right now.   I did mention the symptoms to the physician's assistant last time I was seen though.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Sleep disorder, Vomiting
Clinical narrative: The night after I was vaccinated, I awoke multiple times desperately gasping for air. I do not have apnea or anything like that; it was from the booster shot.  I was feeling progressively worse and worse and by about 6 AM on the 24th of December, I began vomiting more violently than is typical for me when sick. I was drifting in and out of consciousness throughout the morning, only to be awaken by the same gasping for air, except now the gasping was accompanied by a severe need to vomit.  By the evening the vomiting had subsided but I was still extremely nauseous, occasionally out of breath for no reason, and feeling very exhausted.   I did not get out of bed for two days except to vomit, refill my water,  and use the facilities. For two weeks days after the booster shot I was overcome with moderately severe depression.  My body was inflamed for three weeks, with my rings difficult to remove from my fingers. I had a migraine for a week straight after receiving the booster.  It is by far the most sick I have ever been after receiving any type of vaccination.   Oddly enough, the booster left my arm feeling sore for much less time than the first two shots did. But everything else aside from my arm was much, much worse with the booster.   If I had not already been on vacation, I would have missed at least four days of work due to how sick I was from the booster.  The only lingering symptoms I have as of Jan 15, 2020 are very mild global inflammation and depression (more than I normally have)   For this reason, I answered "unknown" for question #20  The side effects I experienced were alarming enough that  I would have gone to the ER under normal circumstances, but I did not go because the hospitals are overwhelmed with covid patients right now.   I did mention the symptoms to the physician's assistant last time I was seen though.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Lip swelling, Lymph node pain, Pain, Swelling face
Clinical narrative: I did a booster shot with Moderna on 1/12/22 and got a side reaction: swollen area around lips, including lower lip, chin and partially lower cheeks. At the evening on 1/14 the symptoms started developing, I massaged the area a bit, drank some water and went to bed. At night I woke up as the aforementioned area got worse (pain, more swollen). I took a pill of Benadryl, applied some Hydrocortisone ointment and went to bed. I could sleep till morning as symptoms pertained. In the morning I scheduled a call with my medical provider (1:50 pm PST) and took one more antihistamine pill (Claritin). I still have one part of my face (left one) bigger than other. Some mild side effects I got on a second day after booster: pain in left under armpit (lymph knot), weakness.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Patient had previously received Pfizer for his primary 2 shots. Today 1/15/2022 the patient came in for a booster shot and elected for Moderna. Patient waited the recommended 15 minutes and at the end of this time he reported to pharmacy staff "I think I am having a reaction". When asked what type of reaction he pulled up his shirt and showed that a patch of hives was developing on the right side of his abdomen. Liquid diphenhydramine was administered and the patient waited on the pharmacy bench for a few minutes. After a few more minutes he said I think I am good and prepared to leave. The patient denied any other symptoms or any history of allergic reactions.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: During a review of the Local Health Dept. internal records, it was found that there might have been a possible temperature excursion with how the vaccine was stored with our mobile vendor.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspepsia, Pruritus, Urticaria
Clinical narrative: 7 days after booster severe heartburn that subsided 3 days later. Approximately 11 days after booster developed severe hives all over body from scalp to feet, randomly appearing with intense itching. Also moves to random spots after 20 to 30 minutes. Seems to be worse in the evening. Taking Zyrtec helps for about 24 hours then tingling on skin returns followed by hives. Now is the 8th consecutive day with hives.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: During a review of the local Department of Health?s internal records, it was found that there might have been a possible temperature excursion with how the vaccine was stored with our mobile vendor.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspepsia, Erythema, Gastrooesophageal reflux disease, Mechanical urticaria
Clinical narrative: Approximately 14 days after receiving my 3rd Moderna dose, I began developing symptoms very similar to dermatographia. Light itching anywhere on my body would turn red very quickly, while prolonged or heavier itching would also result in raised bumps at the site of itching. It would take 30-45 minutes for this redness and swelling to disappear. Around the same time that these symptoms developed, I also began having GERD or heartburn-like sensations, where an uncomfortable pressure would gradually build-up between the chest and esophagus. This pain would last for no more than 5 minutes typically, but occur about 3 times a day throughout the day and night. Currently taking Zyrtec to control some of the itching.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Swelling
Clinical narrative: Approximately 14 days after receiving my 3rd Moderna dose, I began developing symptoms very similar to dermatographia. Light itching anywhere on my body would turn red very quickly, while prolonged or heavier itching would also result in raised bumps at the site of itching. It would take 30-45 minutes for this redness and swelling to disappear. Around the same time that these symptoms developed, I also began having GERD or heartburn-like sensations, where an uncomfortable pressure would gradually build-up between the chest and esophagus. This pain would last for no more than 5 minutes typically, but occur about 3 times a day throughout the day and night. Currently taking Zyrtec to control some of the itching.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Tested Positive for Covid
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Asymptomatic COVID-19, Chills, Decreased appetite, Foreign travel
Clinical narrative: Patient was hospitalized due to breakthrough COVID-19 infection. Patient received 2nd dose in series on 11/09/2021. Patient was hospitalized from 12/23/21 to 12/26/21. Below is copied from discharge summary:   Hospital Course:  Patient s is a 42-yo female with PMH of migraines who presented to the ED with CC of generalied body aches and weakness, headache, chills and decreased appetite. She recently returned from a trip to a Country. She was diagnosed with covid 2 days prior to admission. She also reported she did not take malaria prophylaxis and was concerned for possible malaria infection.  Labs in the ED significant for thrombocytopenia with a platelet count of 54.  Otherwise no leukocytosis.  She had a mild fever of 100.2.  Oxygen saturation was greater than 92 percent on room air and therefore no benefit of IV steroids or remdesivir was deemed to be had.  Patient was admitted to the hospital and started on IV fluids and malaria antigen was checked which was positive.  Infectious Disease was consulted and recommended 3 days of Malarone.  The Paris a tenia was repeated and down to 0.01 from a prior value of 0.17 percent.  She remained asymptomatic from the COVID standpoint in terms of her oxygenation and respiratory symptoms.  She was eating more and did not have any further nausea or vomiting.  She was seen by PT and OT and cleared for discharge home. Thrombocytopenia resolved prior to d/c and labs otherwise stable. She was afebrile.  Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP, within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Laboratory test, Malaria antigen test, Nausea, Pain
Clinical narrative: Patient was hospitalized due to breakthrough COVID-19 infection. Patient received 2nd dose in series on 11/09/2021. Patient was hospitalized from 12/23/21 to 12/26/21. Below is copied from discharge summary:   Hospital Course:  Patient s is a 42-yo female with PMH of migraines who presented to the ED with CC of generalied body aches and weakness, headache, chills and decreased appetite. She recently returned from a trip to a Country. She was diagnosed with covid 2 days prior to admission. She also reported she did not take malaria prophylaxis and was concerned for possible malaria infection.  Labs in the ED significant for thrombocytopenia with a platelet count of 54.  Otherwise no leukocytosis.  She had a mild fever of 100.2.  Oxygen saturation was greater than 92 percent on room air and therefore no benefit of IV steroids or remdesivir was deemed to be had.  Patient was admitted to the hospital and started on IV fluids and malaria antigen was checked which was positive.  Infectious Disease was consulted and recommended 3 days of Malarone.  The Paris a tenia was repeated and down to 0.01 from a prior value of 0.17 percent.  She remained asymptomatic from the COVID standpoint in terms of her oxygenation and respiratory symptoms.  She was eating more and did not have any further nausea or vomiting.  She was seen by PT and OT and cleared for discharge home. Thrombocytopenia resolved prior to d/c and labs otherwise stable. She was afebrile.  Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP, within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Parasitic test positive, Platelet count decreased, SARS-CoV-2 test positive, Thrombocytopenia, Vaccine breakthrough infection
Clinical narrative: Patient was hospitalized due to breakthrough COVID-19 infection. Patient received 2nd dose in series on 11/09/2021. Patient was hospitalized from 12/23/21 to 12/26/21. Below is copied from discharge summary:   Hospital Course:  Patient s is a 42-yo female with PMH of migraines who presented to the ED with CC of generalied body aches and weakness, headache, chills and decreased appetite. She recently returned from a trip to a Country. She was diagnosed with covid 2 days prior to admission. She also reported she did not take malaria prophylaxis and was concerned for possible malaria infection.  Labs in the ED significant for thrombocytopenia with a platelet count of 54.  Otherwise no leukocytosis.  She had a mild fever of 100.2.  Oxygen saturation was greater than 92 percent on room air and therefore no benefit of IV steroids or remdesivir was deemed to be had.  Patient was admitted to the hospital and started on IV fluids and malaria antigen was checked which was positive.  Infectious Disease was consulted and recommended 3 days of Malarone.  The Paris a tenia was repeated and down to 0.01 from a prior value of 0.17 percent.  She remained asymptomatic from the COVID standpoint in terms of her oxygenation and respiratory symptoms.  She was eating more and did not have any further nausea or vomiting.  She was seen by PT and OT and cleared for discharge home. Thrombocytopenia resolved prior to d/c and labs otherwise stable. She was afebrile.  Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP, within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: Patient was hospitalized due to breakthrough COVID-19 infection. Patient received 2nd dose in series on 11/09/2021. Patient was hospitalized from 12/23/21 to 12/26/21. Below is copied from discharge summary:   Hospital Course:  Patient s is a 42-yo female with PMH of migraines who presented to the ED with CC of generalied body aches and weakness, headache, chills and decreased appetite. She recently returned from a trip to a Country. She was diagnosed with covid 2 days prior to admission. She also reported she did not take malaria prophylaxis and was concerned for possible malaria infection.  Labs in the ED significant for thrombocytopenia with a platelet count of 54.  Otherwise no leukocytosis.  She had a mild fever of 100.2.  Oxygen saturation was greater than 92 percent on room air and therefore no benefit of IV steroids or remdesivir was deemed to be had.  Patient was admitted to the hospital and started on IV fluids and malaria antigen was checked which was positive.  Infectious Disease was consulted and recommended 3 days of Malarone.  The Paris a tenia was repeated and down to 0.01 from a prior value of 0.17 percent.  She remained asymptomatic from the COVID standpoint in terms of her oxygenation and respiratory symptoms.  She was eating more and did not have any further nausea or vomiting.  She was seen by PT and OT and cleared for discharge home. Thrombocytopenia resolved prior to d/c and labs otherwise stable. She was afebrile.  Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP, within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Age: 12.0
Sex: M
Vaccine: UNK
Symptoms: Incorrect dose administered
Clinical narrative: Patient given incorrect dose for age group.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: During a review of the local Department of Health?s internal records, it was found that there might have been a possible temperature excursion with how the vaccine was stored with our mobile vendor.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypertension
Clinical narrative: I was found to suddenly have developed hypertension in the neighborhood of 210/110 which was refractory to metoprolol and amlodipine.
Age: 47.0
Sex: F
Vaccine: COVID19, FLUX
Symptoms: Back pain, Discomfort, Feeling abnormal, Headache, Migraine
Clinical narrative: The following morning I had a severe headache. Extreme pressure and felt out of it.  The pain was towards the back, internal part of my head.  It felt like a migraine except that the pressure was not felt in my forehead  as I normally feel with migraines. Nothing relieved my pain except for sleeping.  I also had soreness of the arm and pins, needle like pains on and off.  I had both the COVID booster vaccine and the flu vaccine administered at the same time.  When I had COVID, the headache felt very similar except that with the booster my headache only lasted about 24 hours.
Age: 47.0
Sex: F
Vaccine: COVID19, FLUX
Symptoms: Pain in extremity, Paraesthesia
Clinical narrative: The following morning I had a severe headache. Extreme pressure and felt out of it.  The pain was towards the back, internal part of my head.  It felt like a migraine except that the pressure was not felt in my forehead  as I normally feel with migraines. Nothing relieved my pain except for sleeping.  I also had soreness of the arm and pins, needle like pains on and off.  I had both the COVID booster vaccine and the flu vaccine administered at the same time.  When I had COVID, the headache felt very similar except that with the booster my headache only lasted about 24 hours.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling hot, Syncope
Clinical narrative: Patient received 1st COVID vaccine and was sitting in the waiting area afterward.  He told his fiance that he felt "hot" and was going to the bathroom.  While in there, he passed out and hit the bathroom wall.  He was observed by EMTs and refused transport to the hospital.  He left walking out with his fiance.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: During a review of records, it was found that there might have been a possible temperature excursion with how the vaccine was stored with our mobile vendor.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: patient given wrong dose for age group.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: 12 hours after Pfizer booster shot I experienced rapid heart rate for several hours as well as the next day and I feel I am still experiencing increased heart rate intermittently. Also, feel an increased heart rate with minimal activity. I called doctors office a couple days after third Covid vaccine and was told as long as my heart rate as under 100 no further action needed.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: During a review of the local Department of Health?s internal records, it was found that there might have been a possible temperature excursion with how the vaccine was stored with our mobile vendor.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Ammonia normal, Blood creatinine, Blood culture negative, COVID-19
Clinical narrative: Patient was hospitalized due to breakthrough COVID infection. Patient received J&J vaccine on 05/14/2021. Patient was hospitalized from 12/29/21 - 01/01/22. Below is copied from discharge summary:   Hospital Course:   Patient is a 79 y.o. male with a history of CKD, Hypertension, hyperlipidemia, insulin-dependent diabetes mellitus, coronary artery disease status post CABG, and CVA with residual left-sided weakness presented to the emergency department for altered mental status x1 day prior to admission.   Acute Metabolic Encephalopathy  Resolve Likely 2/2 COVID-19  Ammonia level WNL   Diabetic foot ulcers, right foot Chronic XR neg for osteomyelitis   Blood cultures NGTD Podiatry consulted, no intervention need will follow as OP   COVID-19 viremia  Not  requiring oxygen  COVID-19 order set initiated  Supportive care    AKI on CKD  Resolve Cr at baseline Renally dose medications  Avoid nephrotoxic agents    CHF HFpEF 60%, TTE 8/22/21  No acute decompensation Continue statin and carvedilol    IDDM with hyperglycemia Resume OP tx   Coronary artery disease  CVA with residual left-sided weakness  Continue Plavix   BPH  Continue Flomax   Gastroesophageal reflux disease  Continue Protonix    Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP, MD within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic kidney disease, Condition aggravated, Diabetic foot, Echocardiogram, Mental status changes
Clinical narrative: Patient was hospitalized due to breakthrough COVID infection. Patient received J&J vaccine on 05/14/2021. Patient was hospitalized from 12/29/21 - 01/01/22. Below is copied from discharge summary:   Hospital Course:   Patient is a 79 y.o. male with a history of CKD, Hypertension, hyperlipidemia, insulin-dependent diabetes mellitus, coronary artery disease status post CABG, and CVA with residual left-sided weakness presented to the emergency department for altered mental status x1 day prior to admission.   Acute Metabolic Encephalopathy  Resolve Likely 2/2 COVID-19  Ammonia level WNL   Diabetic foot ulcers, right foot Chronic XR neg for osteomyelitis   Blood cultures NGTD Podiatry consulted, no intervention need will follow as OP   COVID-19 viremia  Not  requiring oxygen  COVID-19 order set initiated  Supportive care    AKI on CKD  Resolve Cr at baseline Renally dose medications  Avoid nephrotoxic agents    CHF HFpEF 60%, TTE 8/22/21  No acute decompensation Continue statin and carvedilol    IDDM with hyperglycemia Resume OP tx   Coronary artery disease  CVA with residual left-sided weakness  Continue Plavix   BPH  Continue Flomax   Gastroesophageal reflux disease  Continue Protonix    Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP, MD within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Metabolic encephalopathy, SARS-CoV-2 test positive, SARS-CoV-2 viraemia, Vaccine breakthrough infection, X-ray limb normal
Clinical narrative: Patient was hospitalized due to breakthrough COVID infection. Patient received J&J vaccine on 05/14/2021. Patient was hospitalized from 12/29/21 - 01/01/22. Below is copied from discharge summary:   Hospital Course:   Patient is a 79 y.o. male with a history of CKD, Hypertension, hyperlipidemia, insulin-dependent diabetes mellitus, coronary artery disease status post CABG, and CVA with residual left-sided weakness presented to the emergency department for altered mental status x1 day prior to admission.   Acute Metabolic Encephalopathy  Resolve Likely 2/2 COVID-19  Ammonia level WNL   Diabetic foot ulcers, right foot Chronic XR neg for osteomyelitis   Blood cultures NGTD Podiatry consulted, no intervention need will follow as OP   COVID-19 viremia  Not  requiring oxygen  COVID-19 order set initiated  Supportive care    AKI on CKD  Resolve Cr at baseline Renally dose medications  Avoid nephrotoxic agents    CHF HFpEF 60%, TTE 8/22/21  No acute decompensation Continue statin and carvedilol    IDDM with hyperglycemia Resume OP tx   Coronary artery disease  CVA with residual left-sided weakness  Continue Plavix   BPH  Continue Flomax   Gastroesophageal reflux disease  Continue Protonix    Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP, MD within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Gait disturbance, Muscular weakness, Tremor
Clinical narrative: After receiving Pfizer vaccine, Husband began having weakness in his legs to the extent that it was hard for him to walk. No pain just major weakness. After booster shot in November he appeared that he was having a stroke as he could not put one foot in front of the other and legs gave out, had the shakes and could not walk.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain lower, Dysmenorrhoea, Menstrual disorder, Ovarian cyst, Ultrasound scan
Clinical narrative: Pain in lower left belly. Pain would continue to come and go, often fairly severe and other times just a nuisance. Began tracking the days it was most noticeable and it seemed to occur around ovulation and lighten up during the start of menstrual cycle. Menstrual cramps became much more painful than normal for most following cycles. The next 4 cycles were about one day longer than normal. Brought up these concerns during my well-woman visit in November 2021 and received ultrasounds and birth control (Falmina). Had to stop taking the birth control due to adverse reactions after 1.5 weeks. As of January 2022, pain is more mild and still comes and goes in the same pattern. Unsure if this is at all related to the vaccine or just a matter of timing, but wanted to report just in case!
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Depression, Tinnitus
Clinical narrative: Loud Tinnitus right ear, induced by booster shot.  Doctor states he?s received a spike in Tinnitus cases resulting from vaccines.  This is a huge issue as failure to treat early and recognize cause can result in a permanent dehabilitating  condition.  It has been 2 and a half weeks and no reduction in high level tinnitus screech in right ear.  Significant depression first 2 weeks,  2nd course of steroids being taken.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia, Pain in jaw, Tinnitus
Clinical narrative: ringing in ears, sore jaw and metallic taste in mouth
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Heavy menstrual bleeding
Clinical narrative: Since receiving the vaccine in February of 2021, my menstrual periods have been SEVERE due to an extraordinary amount of blood and cramping.   My periods still occur regularly on a predictable schedule, but they are EXTREME. For example, before the vaccine I would go through 3-4 super tampons on the first couple days of my period each month. Since getting the vaccine, I go through 5-6 super plus tampons (many times changing them overnight which also never happened before).  Also before the vaccine, I would have cramps the first day, take 3 Ibuprofen, and be done with cramps for the rest of my cycle.  Since taking the vaccine, I have had to take Ibuprofen every day of my period, many days, 2-3 times a day.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea exertional, Echocardiogram normal, Electrocardiogram ambulatory abnormal, Electrocardiogram normal, Palpitations
Clinical narrative: Palpitations, runs of tachycardia, exertional dyspnea.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Tachycardia, Ventricular extrasystoles
Clinical narrative: Palpitations, runs of tachycardia, exertional dyspnea.